Nanomedicine is the medical application of nanotechnology.[1] Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials (materials whose structure is on the scale of nanometers, i.e. billionths of a meter).
Nanomedicine research is receiving funding from the US National Institutes of Health. Of note is the funding in 2005 of a five-year plan to set up four nanomedicine centers. In April 2006, the journal Nature Materials estimated that 130 nanotech-based drugs and delivery systems were being developed worldwide.[2]
The biological and medical research communities have exploited the unique properties of nanomaterials for various applications (e.g., contrast agents for cell imaging and therapeutics for treating cancer). Terms such as biomedical nanotechnology, nanobiotechnology, and nanomedicine are used to describe this hybrid field. Functionalities can be added to nanomaterials by interfacing them with biological molecules or structures. The size of nanomaterials is similar to that of most biological molecules and structures; therefore, nanomaterials can be useful for both in vivo and in vitro biomedical research and applications. Thus far, the integration of nanomaterials with biology has led to the development of diagnostic devices, contrast agents, analytical tools, physical therapy applications, and drug delivery vehicles.
Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices in the near future.[3][4] The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced drug delivery systems, new therapies, and in vivo imaging.[5] Neuro-electronic interfaces and other nanoelectronics-based sensors are another active goal of research. Further down the line, the speculative field of molecular nanotechnology believes that cell repair machines could revolutionize medicine and the medical field.
Nanomedicine is a large industry, with nanomedicine sales reaching $6.8 billion in 2004, and with over 200 companies and 38 products worldwide, a minimum of $3.8 billion in nanotechnology R&D is being invested every year.[6] As the nanomedicine industry continues to grow, it is expected to have a significant impact on the economy.
Two forms of nanomedicine that have already been tested in mice and are awaiting human trials that will be using gold nanoshells to help diagnose and treat cancer,[7] and using liposomes as vaccine adjuvants and as vehicles for drug transport.[8][9] Similarly, drug detoxification is also another application for nanomedicine which has shown promising results in rats.[10] A benefit of using nanoscale for medical technologies is that smaller devices are less invasive and can possibly be implanted inside the body, plus biochemical reaction times are much shorter. These devices are faster and more sensitive than typical drug delivery.[11] Advances in Lipid nanotechnology was also instrumental in engineering medical nanodevices and novel drug delivery systems as well as in developing sensing applications.[12]
Nanotechnology has provided the possibility of delivering drugs to specific cells using nanoparticles. The overall drug consumption and side-effects may be lowered significantly by depositing the active agent in the morbid region only and in no higher dose than needed. This highly selective approach would reduce costs and human suffering. An example can be found in dendrimers and nanoporous materials. Another example is to use block co-polymers, which form micelles for drug encapsulation.[13] They could hold small drug molecules transporting them to the desired location. Another vision is based on small electromechanical systems; nanoelectromechanical systems are being investigated for the active release of drugs. Some potentially important applications include cancer treatment with iron nanoparticles or gold shells. Targeted drug delivery is intended to reduce the side effects of drugs with concomitant decreases in consumption and treatment expenses. The increased efficiency of delivery results in overall societal benefit by reducing the amount of drug needed in an equipotent preparation of said therapy, and thus reduced cost to the consumer.
Nanomedical approaches to drug delivery center on developing nanoscale particles or molecules to improve drug bioavailability. Bioavailability refers to the presence of drug molecules where they are needed in the body and where they will do the most good. Drug delivery focuses on maximizing bioavailability both at specific places in the body and over a period of time. This can potentially be achieved by molecular targeting by nanoengineered devices.[14][15] It is all about targeting the molecules and delivering drugs with cell precision. More than $65 billion are wasted each year due to poor bioavailability. In vivo imaging is another area where tools and devices are being developed. Using nanoparticle contrast agents, images such as ultrasound and MRI have a favorable distribution and improved contrast. The new methods of nanoengineered materials that are being developed might be effective in treating illnesses and diseases such as cancer. What nanoscientists will be able to achieve in the future is beyond current imagination. This might be accomplished by self assembled biocompatible nanodevices that will detect, evaluate, treat and report to the clinical doctor automatically.
Drug delivery systems, lipid- or polymer-based nanoparticles,[13] can be designed to improve the pharmacological and therapeutic properties of drugs.[16] The strength of drug delivery systems is their ability to alter the pharmacokinetics and biodistribution of the drug.[17][18] However, the pharmacokinetics and pharmacodynamics of nanomedicine is highly variable among different patients.[19] When designed to avoid the body's defence mechanisms,[20] nanoparticles have beneficial properties that can be used to improve drug delivery. Where larger particles would have been cleared from the body, cells take up these nanoparticles because of their size. Complex drug delivery mechanisms are being developed, including the ability to get drugs through cell membranes and into cell cytoplasm. Efficiency is important because many diseases depend upon processes within the cell and can only be impeded by drugs that make their way into the cell. Triggered response is one way for drug molecules to be used more efficiently. Drugs are placed in the body and only activate on encountering a particular signal. For example, a drug with poor solubility will be replaced by a drug delivery system where both hydrophilic and hydrophobic environments exist, improving the solubility.[21] Also, a drug may cause tissue damage, but with drug delivery, regulated drug release can eliminate the problem. If a drug is cleared too quickly from the body, this could force a patient to use high doses, but with drug delivery systems clearance can be reduced by altering the pharmacokinetics of the drug. Poor biodistribution is a problem that can affect normal tissues through widespread distribution, but the particulates from drug delivery systems lower the volume of distribution and reduce the effect on non-target tissue. Potential nanodrugs will work by very specific and well-understood mechanisms; one of the major impacts of nanotechnology and nanoscience will be in leading development of completely new drugs with more useful behavior and less side effects.
It is greatly observed that[who?] nanoparticles are promising tools for the advancement of drug delivery, medical imaging, and as diagnostic sensors. However, the biodistribution of these nanoparticles is still imperfect due to the complex host's reactions to nano- and microsized materials[14] and the difficulty in targeting specific organs in the body. Nevertheless, a lot of work is still ongoing to optimize and better understand the potential and limitations of nanoparticulate systems. For example, current research in the excretory systems of mice shows the ability of gold composites to selectively target certain organs based on their size and charge. These composites are encapsulated by a dendrimer and assigned a specific charge and size. Positively-charged gold nanoparticles were found to enter the kidneys while negatively-charged gold nanoparticles remained in the liver and spleen. It is suggested that the positive surface charge of the nanoparticle decreases the rate of opsonization of nanoparticles in the liver, thus affecting the excretory pathway. Even at a relatively small size of 5nm, though, these particles can become compartmentalized in the peripheral tissues, and will therefore accumulate in the body over time. While advancement of research proves that targeting and distribution can be augmented by nanoparticles, the dangers of nanotoxicity become an important next step in further understanding of their medical uses.[22]
View original post here:
Nanomedicine - Wikipedia, the free encyclopedia
- Advances in nanotechnology's fight against cancer - December 27th, 2013 [December 27th, 2013]
- Nanotechnology and Medicine - Nanomedicine and Disease ... - December 27th, 2013 [December 27th, 2013]
- Nanomedicine: Nanotechnology, Biology and Medicine - Official Site - December 27th, 2013 [December 27th, 2013]
- Nanomedicine Fact Sheet - December 27th, 2013 [December 27th, 2013]
- Nanomedicine, bionanotechnology | NanomedicineCenter.com - December 27th, 2013 [December 27th, 2013]
- Nanomedicine for drug delivery - Srinivas Sridhar - Video - December 28th, 2013 [December 28th, 2013]
- IT-CRS 2013 workshop- Prof. Kevin Breackmans. Studying nanomedicine biobarriers - Video - December 30th, 2013 [December 30th, 2013]
- Nanotechnology in Medicine - UnderstandingNano - January 3rd, 2014 [January 3rd, 2014]
- Nanomedicine - Nanorobots in Medicine - UnderstandingNano - January 8th, 2014 [January 8th, 2014]
- Nanomedicine: Challenges and opportunities - Video - January 13th, 2014 [January 13th, 2014]
- Global Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019: Transparency Market Research - January 16th, 2014 [January 16th, 2014]
- NANOMEDICINE 1 - Video - January 17th, 2014 [January 17th, 2014]
- Researchers measure minuscule particles with 'tiny diving boards' - January 20th, 2014 [January 20th, 2014]
- High Unmet Needs in Therapeutics to Spur Growth in the Market for Nanotechnology in Drug Delivery, According to New ... - January 21st, 2014 [January 21st, 2014]
- Nanomedicine Market - Video - January 22nd, 2014 [January 22nd, 2014]
- Nanomedicine and human upper limit - Video - January 23rd, 2014 [January 23rd, 2014]
- Animated Nanomedicine movie - Video - February 2nd, 2014 [February 2nd, 2014]
- In Vitro Innovation: Testing Nanomedicine With Blood Cells On A Microchip - February 4th, 2014 [February 4th, 2014]
- Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019 - February 7th, 2014 [February 7th, 2014]
- NANOMEDICINE 4: AYDEN JACOB FROM UCSF - Video - February 7th, 2014 [February 7th, 2014]
- New Live-Cell Printing Technology Works Like Ancient Chinese Woodblocking - February 10th, 2014 [February 10th, 2014]
- NANOMEDICINE HANGOUT: ARSALAN SHABBIR MD - Video - February 14th, 2014 [February 14th, 2014]
- Using Mathematical Models to Understand Nanoscale Roughness Published by Dove Medical Press - February 17th, 2014 [February 17th, 2014]
- NTU and Northwestern University to set up $70 million nanomedicine research institute - February 20th, 2014 [February 20th, 2014]
- Interview with Medical Animator YURIY SVIDINENKO, about Nanotechnology Videos - Video - February 21st, 2014 [February 21st, 2014]
- TTU MSE nanomedicine lab NML 2013 f - Video - February 21st, 2014 [February 21st, 2014]
- Nanomedicine Vietsubtitles - Video - February 24th, 2014 [February 24th, 2014]
- Biochips for Better Cancer Therapy in NanoMedicine - Video - February 27th, 2014 [February 27th, 2014]
- 13 Nanomedicine Part 1 - Video - February 28th, 2014 [February 28th, 2014]
- 13 Nanomedicine part 2 - Video - February 28th, 2014 [February 28th, 2014]
- practicum nanomedicine pws Nicole en jordy - Video - March 6th, 2014 [March 6th, 2014]
- Nanomedicine, Detto tra Noi, 4 marzo 2014 - Video - March 6th, 2014 [March 6th, 2014]
- Brown Symposium XXXVI - Mauro Ferrari: "Nanomedicine and New Societal Horizons" - Video - March 9th, 2014 [March 9th, 2014]
- nanomedicine nanobiotix itele - Video - March 9th, 2014 [March 9th, 2014]
- NANOMEDICINE HANGOUT UNIVERSITY OF MIAMI ARSALAN SHABBIR MD - Video - March 16th, 2014 [March 16th, 2014]
- NANOMEDICINE HANGOUT1 - Video - March 21st, 2014 [March 21st, 2014]
- NANOMEDICINE HANGOUT - Video - March 21st, 2014 [March 21st, 2014]
- Ideas @Davos | Sonia Trigueros | Breakthroughs in Nanomedicine - Video - March 22nd, 2014 [March 22nd, 2014]
- Nanomedicine: towards development of patient-friendly drug-delivery systems - Video - March 23rd, 2014 [March 23rd, 2014]
- Nanomedicine Research - March 26th, 2014 [March 26th, 2014]
- Mining Genome Information for New Starting Points in Personalized Cancer Nanomedicine - Video - March 28th, 2014 [March 28th, 2014]
- Cancer Stem Cells as Preferential Target for Personalized Cancer Nanomedicine - Video - March 28th, 2014 [March 28th, 2014]
- Nanomedicine Against Malaria: Use of Poly-based Nanovectors for the Drug Delivery to Plasmodium - Video - March 29th, 2014 [March 29th, 2014]
- Panel - The Horizon of Nanomedicine and Targeted Drug Delivery - Video - March 29th, 2014 [March 29th, 2014]
- Panel - The Regulation Environment in Nanomedicine -- The Step to the Last Phase of Translation - Video - March 29th, 2014 [March 29th, 2014]
- Looking and Listening to Light from Liposome Nanostructures for Cancer Theranostics - Video - March 29th, 2014 [March 29th, 2014]
- Nanobiotix Selected to Present Data from NBTXR3 Clinical Trial at the 50th Annual Meeting of the American Society of ... - April 2nd, 2014 [April 2nd, 2014]
- Breakthroughs in Nanomedicine-A World Economic Forum Discussion-Ideas @Davos-WIRED - Video - April 4th, 2014 [April 4th, 2014]
- How IBM Is Using Nanotechnology To Tackle MRSA And HIV - April 5th, 2014 [April 5th, 2014]
- In latest generation of tiny biosensors, size isn't everything - April 14th, 2014 [April 14th, 2014]
- Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global ... - April 17th, 2014 [April 17th, 2014]
- doctors-hospital-surgery-AFprelax-210414.jpg - April 21st, 2014 [April 21st, 2014]
- Nanomedicine - Video - April 25th, 2014 [April 25th, 2014]
- Nanomedicine Presentation - Video - May 6th, 2014 [May 6th, 2014]
- Nanomedicine Promo - Video - May 6th, 2014 [May 6th, 2014]
- A skinful of nanoparticles starts to show - May 16th, 2014 [May 16th, 2014]
- nanomedicine edit1 - Video - May 17th, 2014 [May 17th, 2014]
- UB spinoff Nanobiotix working to bring cancer treatment to market - May 29th, 2014 [May 29th, 2014]
- DGAP-News: MagForce AG: MagForce AG to present at dbAccess German, Swiss & Austrian Conference 2014, held by Deutsche ... - June 2nd, 2014 [June 2nd, 2014]
- New nanomedicine by NTU and SERI scientists to bring relief to glaucoma patients - June 4th, 2014 [June 4th, 2014]
- New glaucoma treatment replaces the hassle of applying eyedrops daily - June 4th, 2014 [June 4th, 2014]
- Cancer Nanomedicine - The Cancer Nanomedicine Blog - June 5th, 2014 [June 5th, 2014]
- No More Eye Drops for Glaucoma - June 10th, 2014 [June 10th, 2014]
- Nanomatriaux 2014 - AGuIX in nanomedicine - Video - June 19th, 2014 [June 19th, 2014]
- Introduction to nanomedicine with emphasis on carrier-mediated drug targeting - Video - June 20th, 2014 [June 20th, 2014]
- Challenging the Old Order to Set New Frontiers in Nanoscience & Nanotechnology - June 21st, 2014 [June 21st, 2014]
- Welcome - Summer School on Nanomedicine and Innovation - Video - June 24th, 2014 [June 24th, 2014]
- Nanomedicine and IP - Video - June 25th, 2014 [June 25th, 2014]
- Global Nanomedicine Market: Industry Analysis, Size, Share,Growth, Trends, and Forecast 2013 - 2019 - June 30th, 2014 [June 30th, 2014]
- Scientists engineer nanoparticles to prevent bone cancer, strengthen bones - July 2nd, 2014 [July 2nd, 2014]
- Global Nanomedicine Market Projected to be Worth USD 177.60 billion by 2019 - July 4th, 2014 [July 4th, 2014]
- Nanobiotix revenue for the 2nd quarter of 2014 - July 11th, 2014 [July 11th, 2014]
- magforce - Using advanced nanomedicine for innovative therapies - Video - July 25th, 2014 [July 25th, 2014]
- Shelton firms products in the pipeline could end diseases - July 29th, 2014 [July 29th, 2014]
- In the Quest to Treat Intracerebral Hemorrhage, Nanomaterials Show Promise - July 31st, 2014 [July 31st, 2014]
- Researchers to track effects of revolutionary new medicines - August 8th, 2014 [August 8th, 2014]
- Nanomedicine & RA with Dr. Bottini - Video - August 8th, 2014 [August 8th, 2014]
- Cellular Surgeons: The New Era of Nanomedicine - Full Program - Video - August 8th, 2014 [August 8th, 2014]
- DGAP-News: MagForce AG: Successful final closing of a growth financing round for MagForce USA, Inc. under the lead of ... - August 9th, 2014 [August 9th, 2014]
- Training the next generation of cancer nanomedicine scientists - August 19th, 2014 [August 19th, 2014]